Mercator Medical Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Mercator Medical.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 19.0% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | None |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Improved Revenues Required Before Mercator Medical S.A. (WSE:MRC) Stock's 31% Jump Looks Justified
Aug 22
Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively
Jun 06Returns At Mercator Medical (WSE:MRC) Are On The Way Up
Sep 23Should You Be Adding Mercator Medical (WSE:MRC) To Your Watchlist Today?
Nov 06Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?
Jul 13Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations
May 19What Kind Of Shareholders Hold The Majority In Mercator Medical S.A.'s (WSE:MRC) Shares?
Dec 23
En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Mercator Medical no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.
Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2024 | 489 | -2 | -20 | 3 | N/A |
| 3/31/2024 | 487 | 9 | -20 | 8 | N/A |
| 12/31/2023 | 469 | -20 | -39 | 0 | N/A |
| 9/30/2023 | 470 | -232 | -33 | 33 | N/A |
| 6/30/2023 | 491 | -194 | -37 | 46 | N/A |
| 3/31/2023 | 519 | -214 | -95 | 2 | N/A |
| 12/31/2022 | 543 | -190 | -69 | 41 | N/A |
| 9/30/2022 | 704 | 20 | -7 | 121 | N/A |
| 6/30/2022 | 926 | 41 | -12 | 162 | N/A |
| 3/31/2022 | 1,314 | 167 | 195 | 370 | N/A |
| 12/31/2021 | 1,729 | 447 | 326 | 503 | N/A |
| 9/30/2021 | 2,103 | 789 | 438 | 569 | N/A |
| 6/30/2021 | 2,334 | 1,102 | 801 | 865 | N/A |
| 3/31/2021 | 2,185 | 1,195 | 828 | 868 | N/A |
| 12/31/2020 | 1,835 | 930 | 697 | 712 | N/A |
| 9/30/2020 | 1,319 | 583 | 529 | 540 | N/A |
| 6/30/2020 | 872 | 230 | 189 | 202 | N/A |
| 3/31/2020 | 621 | 23 | 2 | 19 | N/A |
| 12/31/2019 | 540 | -2 | 23 | 39 | N/A |
| 9/30/2019 | 534 | -1 | 27 | 43 | N/A |
| 6/30/2019 | 501 | 0 | 22 | 43 | N/A |
| 3/31/2019 | 452 | -1 | -3 | 24 | N/A |
| 12/31/2018 | 420 | 8 | -51 | -8 | N/A |
| 9/30/2018 | 364 | 9 | -63 | 7 | N/A |
| 6/30/2018 | 330 | 10 | -70 | 9 | N/A |
| 3/31/2018 | 316 | 10 | N/A | 22 | N/A |
| 12/31/2017 | 301 | 5 | N/A | 24 | N/A |
| 9/30/2017 | 292 | 5 | N/A | 9 | N/A |
| 6/30/2017 | 284 | 8 | N/A | 9 | N/A |
| 3/31/2017 | 278 | 11 | N/A | 19 | N/A |
| 12/31/2016 | 264 | 14 | N/A | 17 | N/A |
| 9/30/2016 | 259 | 14 | N/A | 19 | N/A |
| 6/30/2016 | 254 | 11 | N/A | 13 | N/A |
| 3/31/2016 | 238 | 10 | N/A | 5 | N/A |
| 12/31/2015 | 227 | 10 | N/A | 8 | N/A |
| 9/30/2015 | 211 | 11 | N/A | 9 | N/A |
| 6/30/2015 | 193 | 12 | N/A | 4 | N/A |
| 3/31/2015 | 181 | 12 | N/A | 5 | N/A |
| 12/31/2014 | 168 | 10 | N/A | 13 | N/A |
| 9/30/2014 | 160 | 8 | N/A | 5 | N/A |
| 6/30/2014 | 154 | 7 | N/A | 8 | N/A |
| 3/31/2014 | 151 | 6 | N/A | 0 | N/A |
| 12/31/2013 | 148 | 7 | N/A | 2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if MRC's forecast earnings growth is above the savings rate (3.9%).
Beneficios vs. Mercado: Insufficient data to determine if MRC's earnings are forecast to grow faster than the Polish market
Beneficios de alto crecimiento: Insufficient data to determine if MRC's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: Insufficient data to determine if MRC's revenue is forecast to grow faster than the Polish market.
Ingresos de alto crecimiento: Insufficient data to determine if MRC's revenue is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if MRC's Return on Equity is forecast to be high in 3 years time